Sengsayadeth, S., Savani, B. N., Jagasia, M., Goodman, S., Greer, J. P., Chen, H., . . . Engelhardt, B. G. (2013). Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials.
Dyfyniad Arddull ChicagoSengsayadeth, Salyka, Bipin N. Savani, Madan Jagasia, Stacey Goodman, John P. Greer, Heidi Chen, Wichai Chinratanalab, Adetola A. Kassim, and Brian G. Engelhardt. Six Month Freedom From Treatment Failure Is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials. 2013.
Dyfyniad MLASengsayadeth, Salyka, et al. Six Month Freedom From Treatment Failure Is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials. 2013.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.